On August 28, 2024 BridgeBio Pharma, Inc. (Nasdaq: BBIO) (BridgeBio), a commercial-stage biopharmaceutical company focused on genetic diseases, reported that members of the management team will participate in the following upcoming investor conferences (Press release, BridgeBio, AUG 28, 2024, View Source [SID1234646149]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Morgan Stanley 22nd Annual Global Health Care Conference, New York, NY: Fireside Conversation on September 4th at 10:00 am ET
Wells Fargo 19th Annual Healthcare Conference 2024, Boston, MA, September 5th
Cantor Global Healthcare Conference, New York, NY: Presentation on September 17th at 10:20 am ET

To access the live webcast of BridgeBio’s presentations, please visit the "Events" page within the Investors section of the BridgeBio website at View Source A replay of the webcasts will be available on the BridgeBio website for 90 days following the event.